• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEXCOM, INC. DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM; MDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEXCOM, INC. DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM; MDS Back to Search Results
Model Number 9500-27
Device Problem Invalid Sensing (2293)
Patient Problems Hypoglycemia (1912); Seizures (2063); Loss of consciousness (2418)
Event Date 05/08/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Diabetes mellitus is a known cause of loss of consciousness, hypoglycemia and its associated effects.
 
Event Description
Patient contacted dexcom on 05/09/2016 to report that they experienced continuous glucose monitoring (cgm) inaccuracies and an adverse event on (b)(6) 2016.The sensor was inserted into the thigh on (b)(6) 2016.Patient stated that they had a seizure immediately after doing a blood glucose (bg) check at 12:12 pm.The patient had eaten at 9:30 am and used an extended bolus.Patient stated that at 12:12 pm the bg meter was reading 40mg/dl but cgm read 61mg/dl.Patient was trying to calculate how many carbohydrates to eat to increase their bg.The next thing they remember was that 15 minutes later they were on the bathroom floor, after the patient's wife administered 2 bottles of liquid glucose (30 grams).Patient stated that it was too much glucose but they were able to get their bg down to an almost acceptable level of 142mg/dl by bedtime.Patient was not taken to the hospital.At the time of contact, the patient was in good condition.No additional event or patient information was provided.Data was available for review.However, date range for data did not cover the date of event.The reported complaint of cgm inaccuracies could not be confirmed.A root cause was not determined.Additionally, the sensor was inserted into the thigh.The dexcom g5 cgm system user's guide states: do not insert the sensor component of the dexcom g5 mobile system in a site other than the belly/abdomen (ages 2 years and older) or the upper buttocks (ages 2 to 17 years).The placement and insertion of the sensor component of the dexcom g5 mobile system is not approved for other sites.If placed in other areas, the dexcom g5 mobile system may not function properly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM
Type of Device
MDS
Manufacturer (Section D)
DEXCOM, INC.
6340 sequence drive
san diego CA 92121
Manufacturer (Section G)
DEXCOM, INC.
6340 sequence drive
san diego CA 92121
Manufacturer Contact
kipp durbin
6340 sequence drive
san diego, CA 92121
8582000200
MDR Report Key5699419
MDR Text Key46559904
Report Number3004753838-2016-03307
Device Sequence Number1
Product Code MDS
UDI-Device Identifier00386270000019
UDI-Public(01)00386270000019(241)9500-27(10)5207640(17)161227
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120005
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 05/09/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/27/2016
Device Model Number9500-27
Device Catalogue NumberSTS-GL-011
Device Lot Number5207640
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received05/09/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/23/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age72 YR
Patient Weight79
-
-